We are live on ! Find out more
ABEOW

Abeona Therapeutics Inc Warrant
ABEOW

Delisted

ABEOW was delisted on the 20th of December, 2019.

Back to rankings

5 hedge funds and large institutions have $15.9M invested in Abeona Therapeutics Inc Warrant in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $14.7M → $15.9M (+$1.11M)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$10.9K

Top Sellers

Rank Fund Capital Flow
1
OFG
OTA Financial Group
New York
-$2.05K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Perceptive Advisors
New York
$12.8M – – –
HCM
2
Highbridge Capital Management
New York
$2.67M – – –
OFG
3
OTA Financial Group
New York
$360K -$2.05K -158 -0.4%
UBS Group
4
UBS Group
Switzerland
$11K +$10.9K +843 +344%
Bank of America
5
Bank of America
North Carolina
$1K – – –

ABEOW Hedge Fund Activity: Q2 2018 in Review

5 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q2 2018, worth a combined $15.9M — up 7.6% from $14.7M a quarter earlier.

Fund positioning in ABEOW was balanced in Q2 2018: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $10.9K. The largest seller was OTA Financial Group, cutting an estimated $2.05K.

  • 5 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $15.9M of Abeona Therapeutics Inc Warrant stock for Q2 2018, up 7.6% quarter-over-quarter.
  • 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q2 2018 and 0 closed out.
  • The largest Abeona Therapeutics Inc Warrant buyer in Q2 2018 was UBS Group, an estimated $10.9K added.
  • The largest Abeona Therapeutics Inc Warrant seller in Q2 2018 was OTA Financial Group, an estimated $2.05K sold.

Based on aggregated 13F filings for Q2 2018.